Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial

Sandra L Carroll, Michael McGillion, Dawn Stacey, Jeff S Healey, Gina Browne, Heather M Arthur, Lehana Thabane, Sandra L Carroll, Michael McGillion, Dawn Stacey, Jeff S Healey, Gina Browne, Heather M Arthur, Lehana Thabane

Abstract

Background: Patients, identified to be at risk for but who have never experienced a potentially lethal cardiac arrhythmia, have the option of receiving an implantable cardioverter defibrillator (ICD) as prophylaxis against sudden cardiac death - a primary prevention indication. In Canada, there is no clear framework to support patients' decision-making for these devices. Decision support, using a decision aid, could moderate treatment-related uncertainty and prepare patients to make well-informed decisions. Patient decision aids provide information on treatment options, risks, and benefits, to help patients clarify their values for outcomes of treatment options. The objectives of this research are: 1) develop a decision aid, 2) evaluate the decision aid, and 3) determine the feasibility of conducting a trial.

Methods/design: A development panel comprised of the core investigative team, health service researchers, decision science experts, cardiovascular healthcare practitioners, and ICD patient representatives will collaborate to provide input on the content and format of the aid. To generate probabilities to include in the aid, we will synthesize primary prevention ICD evidence. To obtain anonymous input about the facts and content, we will employ a modified Delphi process. To evaluate the draft decision aid will invite ICD patients and their families (n = 30) to rate its acceptability. After we evaluate the aid, to determine the feasibility, we will conduct a feasibility pilot randomized controlled trial (RCT) in new ICD candidates (n = 80). Participants will be randomized to receive a decision aid prior to specialist consultation versus usual care. Results from the pilot RCT will determine the feasibility of research processes; inform sample size calculation, measure decision quality (knowledge, values, decision conflict) and the influence of health related quality of life on decision-making.

Discussion: Our study seeks to develop a decision aid, for patients offered their first ICD for prophylaxis against sudden cardiac death. This paper outlines the background and methods of a pilot randomized trial which will inform a larger multicenter trial. Ultimately, decision support prior to specialist consultation could enhance the decision-making process between patients, physicians, and families, associated with life-prolonging medical devices like the ICD.

Trial registration: ClinicalTrials.gov: NCT01876173.

Figures

Figure 1
Figure 1
Feasibility pilot randomized controlled trial.

References

    1. Tang AS, Ross H, Simpson CS, Mitchell LB, Dorian P, Goeree R. et al.Canadian cardiovascular society/Canadian heart rhythm society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol. 2005;14:11A–18A.
    1. Byrne R, Constant O, Smyth Y, Callagy G, Nash P, Daly K. et al.Multiple source surveillance incidence and etiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland. Eur Heart J. 2008;14:1418–1423. doi: 10.1093/eurheartj/ehn155.
    1. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P. et al.Task force on sudden cardiac death of the European society of cardiology. Eur Heart J. 2001;14:1374–1450. doi: 10.1053/euhj.2001.2824.
    1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De SG. et al.Heart disease and stroke statistics - 2010 update: a report from the American heart association.[erratum appears in circulation. 30 March 2010;121(12):e260 note: Stafford, Randall [corrected to Roger, Veronique L]] Circulation. 2010;14:e46–e215.
    1. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP. et al.Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics versus implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study. Eur Heart J. 2000;14:2071–2078. doi: 10.1053/euhj.2000.2476.
    1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS. et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med. 2002;14:877–883. doi: 10.1056/NEJMoa013474.
    1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R. et al.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;14:225–237. doi: 10.1056/NEJMoa043399.
    1. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP. et al.Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New Engl J Med. 2004;14:2151–2158. doi: 10.1056/NEJMoa033088.
    1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT. et al.Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;14:2140–2150. doi: 10.1056/NEJMoa032423.
    1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H. et al.Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. New Engl J Med. 1996;14:1933–1940. doi: 10.1056/NEJM199612263352601.
    1. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S. et al.Cardiac-resynchronization therapy for mild-to-moderate heart failure. New Engl J Med. 2010;14:2385–2395. doi: 10.1056/NEJMoa1009540.
    1. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP. et al.Cardiac-resynchronization therapy for the prevention of heart-failure events. New Engl J Med. 2009;14:1329–1338. doi: 10.1056/NEJMoa0906431.
    1. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JGF. Cardiac resynchronization for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis. Eur J Heart Fail. 2006;14:433–440. doi: 10.1016/j.ejheart.2005.11.014.
    1. Wells G, Parkash R, Healey JS, Talajic M, Arnold JM, Sullivan S. et al.Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials. CMAJ. 2011;14:421–429. doi: 10.1503/cmaj.101685.
    1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS. et al.ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. J Am Coll Cardiol. 2008;14:e1–e62. doi: 10.1016/j.jacc.2008.02.032.
    1. Fishman GI, Chugh SS, DiMarco JP, Albert CM, Anderson ME, Bonow RO. et al.Sudden cardiac death prediction and prevention: report from a national heart, lung, and blood institute and heart rhythm society workshop. Circ. 2010;14:2335–2348. doi: 10.1161/CIRCULATIONAHA.110.976092.
    1. Simpson CS, Hoffmaster B, Dorian P. Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing. Can J Card. 2005;14:595–599.
    1. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB. et al.Pacemaker and ICD generator malfunctions. JAMA. 2006;14:1901–1906. doi: 10.1001/jama.295.16.1901.
    1. Gould PA, Krahn AD. for the Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;14:1907–1911. doi: 10.1001/jama.295.16.1907.
    1. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace. 2009;14:297–302. doi: 10.1093/europace/eun322.
    1. Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P. et al.Predictors of short-term complications after implantable cardioverter-defibrillator replacement/clinical perspective. Circ: Arrhythmia and Electrophysiology. 2011;14:136–142. doi: 10.1161/CIRCEP.110.959791.
    1. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P. et al.Evaluation of early complications related to de novo cardioverter defibrillator implantation: insights from the Ontario ICD database. J Am Coll Cardiol. 2010;14:774–782. doi: 10.1016/j.jacc.2009.11.029.
    1. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M. et al.Decision aids for people facing health treatment or screening decisions. [Update of Cochrane database syst Rev. 2009;(3):CD001431; PMID: 19588325] Cochrane Database of Syst Rev. 2011;14:CD001431.
    1. O’Connor AM. IPDAS Collaboration Background Document. 2005. .
    1. McAlister FA, Man-Son-Hing M, Straus SE, Ghali WA, Anderson D, Majumdar SR. et al.Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial. CMAJ. 2005;14:496–501. doi: 10.1503/cmaj.050091.
    1. Man-Son-Hing M, Laupacis A, O’Connor AM, Biggs J, Drake E, Yetisir E. et al.A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation. JAMA. 1999;14:737–743. doi: 10.1001/jama.282.8.737.
    1. Morgan M, Deber R, Llewellyn-Thomas H, Gladstone P, Cusimano R, O’Rourke K. et al.Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med. 2000;14:685–693. doi: 10.1046/j.1525-1497.2000.91139.x.
    1. Bernstein SJ, Skarupski KA, Grayson CE, Starling MR, Bates ER, Eagle KA. A randomized controlled trial of information-giving to patients referred for coronary angiography: effects on outcomes of care. Health Expect. 1998;14:50–61. doi: 10.1046/j.1369-6513.1998.00007.x.
    1. Schwalm JD, Stacey D, Pericak D, Natarajan MK. Radial artery versus femoral artery access options in coronary angiogram procedures: randomized controlled trial of a patient-decision aid. Circ Cardiovasc Qual Outcomes. 2012;14:260–266. doi: 10.1161/CIRCOUTCOMES.111.962837.
    1. Carroll SL, Strachan PH, de Laat S, Schwartz L, Arthur HM. Patients’ decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expect. 2013;14:69–79. doi: 10.1111/j.1369-7625.2011.00703.x.
    1. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango) Soc Sci & Med. 1997;14:681–692. doi: 10.1016/S0277-9536(96)00221-3.
    1. Edwards A, Elwyn G. Shared Decision-making. Achieving Evidence-based Patient Choice. Oxford: Oxford University Press; 2009.
    1. Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD. et al.Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol. 2009;14:1259–1271. doi: 10.1111/j.1540-8159.2009.02495.x.
    1. Dunbar SB, Jenkins LS, Hawthorne M, Kimble LP, Dudley WN, Slemmons M. et al.Factors associated with outcomes three months after implantable cardioverter defibrillator insertion. Heart Lung. 1999;14:303–315. doi: 10.1053/hl.1999.v28.a101052.
    1. Pedersen SS, van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RAM. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med. 2004;14:714–719. doi: 10.1097/01.psy.0000132874.52202.21.
    1. Pedersen SS, van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RAM. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005;14:664–669. doi: 10.1016/j.ahj.2004.06.031.
    1. Sears SF, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clinl Cardio. 1999;14:481–489. doi: 10.1002/clc.4960220709.
    1. Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RA, Jordaens L. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life three months post-implantation. Europace. 2007;14:675–680. doi: 10.1093/europace/eum041.
    1. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosom: J Consult Liaison Psychiatry. 2005;14:451–457.
    1. Pedersen SS, Van Den Broek KC, Van Den Berg M, Theuns DA. Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: is there more to it than meets the eye? Pace-Pacing Clin Electrophysiol. 2010;14:1430–1436. doi: 10.1111/j.1540-8159.2010.02845.x.
    1. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002;14:488–493. doi: 10.1136/heart.87.5.488.
    1. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace. 2003;14:381–389. doi: 10.1016/S1099-5129(03)00078-3.
    1. Carroll SL, Markle-Reid M, Ciliska D, Connolly SJ, Arthur HM. Age and mental health predict early device-specific quality of life (QOL) in patients receiving prophylactic implantable defibrillators. Can J Card. 2012;14:502–507. doi: 10.1016/j.cjca.2012.01.008.
    1. O’Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G. et al.A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998;14:267–279. doi: 10.1016/S0738-3991(98)00026-3.
    1. O’Connor AM. Ottawa Decision Support Framework. 2006. .
    1. O’Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G. et al.Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making. 1998;14:295–303. doi: 10.1177/0272989X9801800307.
    1. Mitchell SL, Tetroe J, O’Connor AM. A decision aid for long-term tube feeding in cognitively impaired older persons. J Am Geriatr Soc. 2001;14:313–316. doi: 10.1046/j.1532-5415.2001.4930313.x.
    1. Dales RE, O’Connor A, Hebert P, Sullivan K, McKim D, Llewellyn-Thomas H. Intubation and mechanical ventilation for COPD: development of an instrument to elicit patient preferences. Chest. 1999;14:792–800. doi: 10.1378/chest.116.3.792.
    1. Cranney A, O’Connor AM, Jacobsen MJ, Tugwell P, Adachi JD, Ooi DS. et al.Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns. 2002;14:245–255. doi: 10.1016/S0738-3991(01)00218-X.
    1. Fiset V, O’Connor AM, Evans W, Graham I, DeGrasse C, Logan J. Development and evaluation of a decision aid for patients with stage IV non-small cell lung cancer. Health Expect. 2000;14:125–136. doi: 10.1046/j.1369-6513.2000.00067.x.
    1. Metcalf KA, Poll A, O’Connor A, Gershman S, Armel S, Finch A. et al.Development and testing of a decision aid for breast cancer prevention for women with BRCA1 or BRCA2 mutation. Clin Genet. 2007;14:208–217. doi: 10.1111/j.1399-0004.2007.00859.x.
    1. O’Connor AM, Edwards A. In: Evidence-based Patient Choice: Inevitable or Impossible? Edwards A, Elwyn G, editor. New York, NY: Oxford University Press; 2001. The role of decision aids in promoting evidence-based patient choice; pp. 220–242.
    1. Gagnon M. In: Knowledge Translation in Health Care: Moving from Evidence to Practice. Straus SE, Tetroe J, Graham ID, editor. Oxford: Wiley-Blackwell Publishing Ltd; 2009. Knowledge dissemination and exchange of knowledge; pp. 235–245.
    1. Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischemic or non-ischemic heart disease: a systematic review and meta-analysis. Europace. 2010;14:1564–1570. doi: 10.1093/europace/euq329.
    1. Ho C, Li H, Noorani H, Cimon K, Campbell K, Tang A, Birnie D. Implantable Cardiac Defibrillators for Primary Prevention of Sudden Cardiac Death in High Risk Patients: A Meta-analysis of Clinical Efficacy, and a Review of Cost-effectiveness and Psychosocial Issues, Technology report number 81. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2007.
    1. Leon AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J. et al.Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol. 2005;14:2348–2356. doi: 10.1016/j.jacc.2005.08.031.
    1. Keeney S, Hasson F, McKenna HP. A critical review of the Delphi technique as a research methodology for nursing. Int Journ Nurs Stud. 2001;14:195–200. doi: 10.1016/S0020-7489(00)00044-4.
    1. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;14:1008–1015.
    1. O’Connor AM, Jacobsen MJ. Workbook on Developing and Evaluating Patient Decision Aids. 2003. .
    1. O’Connor AM, Cranney A. User Manual - Acceptability. Ottawa Hospital Research Institute; 2002. pp. 1–5. , 1-6-2011.
    1. Medical Research Council Health Services and Public Health Research Board. A Framework for Development and Evaluation of RCT’s for Complex Interventions to Improve Health. UK: Medical Research Council; 2000.
    1. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios L. et al.A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;14:1. doi: 10.1186/1471-2288-10-1.
    1. McHorney CA, War JE Jr, Lu JFR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;14:40–66. doi: 10.1097/00005650-199401000-00004.
    1. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas. 1977;14:385–401. doi: 10.1177/014662167700100306.
    1. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977;14:203–214.
    1. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9. Boston, MA: Little Brown; 1994.
    1. Matlock DD, Nowels CT, Bekelman DB. Patient perspectives on decision making in heart failure. J Card Fail. 2010;14:823–826. doi: 10.1016/j.cardfail.2010.06.003.
    1. O’Connor AM. User Manual-decisional Conflict Scale [Document on the internet] Ottawa: Ottawa Hospital Research Institute; © 1993 [updated 2010]: 16p. .
    1. O’Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;14:25–30. doi: 10.1177/0272989X9501500105.
    1. O’Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB. et al.Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;14:CD001431. DOI: 10.1002/14651858.CD001431.pub2.
    1. Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O’Connor AM. Validation of a preparation for decision making scale. Patient Educ Couns. 2010;14:130–133. doi: 10.1016/j.pec.2009.05.012.
    1. Graham ID, O’Connor AM. User Manual-preparation for Decision Making Scale. Ottawa Hospital Research Institute; 2010. pp. 1–3. , 1-6-2011.
    1. Norman GR, Streiner DL. Biostatistics: The Bare Essentials. 3. Hamilton: BC Decker Inc; 2008.
    1. Ryan GW, Bernard HR. Techniques to identify themes. Field Methods. 2003;14:85–109. doi: 10.1177/1525822X02239569.
    1. Thorne S, Kirkham SR, O’Flynn-Magee K. The analytic challenge in interpretive description. Int J Qualitative Methods. 2004;14:1–11.
    1. Thorne S, Kirkham SR, MacDonald-Emes J. Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health. 1997;14:169–177. doi: 10.1002/(SICI)1098-240X(199704)20:2<169::AID-NUR9>;2-I.
    1. Garrett DD, Tuokko H, Stajduhar KI, Lindsay J, Buehler S. Planning for end-of-life care: findings from the Canadian study of health and aging. Can J Aging. 2008;14:11–21. doi: 10.3138/cja.27.1.11.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren